Insights into HIV-1 capsid inhibitors in preclinical and early clinical development as antiretroviral agents

Muge Cevik, Chloe Orkin

Research output: Contribution to journal › Editorial › peer-review

Original languageEnglish
Pages (from-to)1-4
JournalExpert Opinion on Investigational Drugs
VolumeLatest Articles
Early online date18 Nov 2019
DOIs
Publication statusE-pub ahead of print - 18 Nov 2019

Keywords

  • Capsid inhibitors
  • Capsid protein
  • HIV
  • HIV-1
  • Anteretrovirals
  • Capsid assembly

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  • SDG 3 - Good Health and Well-being

Access to Document

  • Capsidinhibitors_v3_26Oct_clean

    Copyright © 2019 Informa UK Limited, trading as Taylor & Francis Group. This work has been made available online in accordance with publisher policies or with permission. Permission for further reuse of this content should be sought from the publisher or the rights holder. This is the author created accepted manuscript following peer review and may differ slightly from the final published version. The final published version of this work is available at https://doi.org/10.1080/13543784.2019.1692811

    Accepted author manuscript, 347 KB

    Cite this